When does rheumatoid arthritis begin and why do we need to know?

[1]  Paul Wordsworth,et al.  Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. , 1994, Arthritis and rheumatism.

[2]  M. V. van Leeuwen,et al.  PROGNOSTIC FACTORS FOR RADIOGRAPHIC DAMAGE AND PHYSICAL DISABILITY IN EARLY RHEUMATOID ARTHRITIS. A PROSPECTIVE FOLLOW-UP STUDY OF 147 PATIENTS , 1992 .

[3]  A M Walker,et al.  The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[4]  A. Silman,et al.  Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years. , 1993, British journal of rheumatology.

[5]  I. Maurer-Fogy,et al.  Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. , 1992, The Journal of clinical investigation.

[6]  H. Dodge,et al.  A four year follow-up of suspected rheumatoid arthritis: the Tecumseh, Michigan, Community Health Study. , 1969, Arthritis and rheumatism.

[7]  G. Firestein,et al.  Early synovitis--synoviocytes and mononuclear cells. , 1994, Seminars in arthritis and rheumatism.

[8]  Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. , 1993, British journal of rheumatology.

[9]  K. Eberhardt,et al.  HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis--their relation to disease progression. , 1993, The Journal of rheumatology.

[10]  M. Weinblatt,et al.  Rheumatoid Arthritis: Treat Now, Not Later! , 1996, Annals of Internal Medicine.

[11]  F. Breedveld,et al.  Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. , 1998, British journal of rheumatology.

[12]  G. Chatellier,et al.  Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. , 1996, British journal of rheumatology.

[13]  A. Zwinderman,et al.  Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. , 1991, Arthritis and rheumatism.

[14]  G. Kolarz,et al.  Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. , 1989, Arthritis and rheumatism.

[15]  A. Masi,et al.  Prognosis in rheumatoid arthritis. A longitudinal study of newly diagnosed younger adult patients. , 1979, The American journal of medicine.

[16]  H. Zeidler,et al.  Undifferentiated arthritis in an early synovitis out-patient clinic. , 1995, Clinical and experimental rheumatology.

[17]  R. Holder,et al.  The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome. , 1997, The Journal of rheumatology.

[18]  G. Alarcón,et al.  Seronegative rheumatoid arthritis. , 1982 .

[19]  F. Wolfe,et al.  The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. , 1993, The Journal of rheumatology.

[20]  J. Ilonen,et al.  Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with “sawtooth” strategy , 1998, Annals of the rheumatic diseases.

[21]  T. Koepsell,et al.  Evaluation of the 1987 revised criteria for rheumatoid arthritis in a cohort of newly diagnosed female patients. , 1990, Arthritis & Rheumatism.

[22]  K. Walton,et al.  Clinical features, autoantibodies and HLA-DR antigens in rheumatoid arthritis. , 1985, The Journal of rheumatology.

[23]  T. Möttönen,et al.  Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. , 1988, Annals of the rheumatic diseases.

[24]  W. Epstein,et al.  Expectation bias in rheumatoid arthritis clinical trials. The anti-CD4 monoclonal antibody experience. , 1996, Arthritis and rheumatism.

[25]  J. Salonen,et al.  When does rheumatoid disease start? , 1985, Arthritis and rheumatism.

[26]  S. Sarna,et al.  Prognosis of inflammatory joint diseases. A three-year follow-up study. , 1983, Scandinavian journal of rheumatology.

[27]  A. Calin,et al.  Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study. , 1989, Arthritis and rheumatism.

[28]  W. Hassfeld,et al.  Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritis. , 1999, Rheumatology.

[29]  P. Brooks.  The Heberden Oration 1997. Treatment of rheumatoid arthritis: from symptomatic relief to potential cure. , 1998, British journal of rheumatology.

[30]  A. Silman,et al.  Natural remission in inflammatory polyarthritis: issues of definition and prediction. , 1996, British journal of rheumatology.

[31]  F. Wollheim.  Predictors of joint damage in rheumatoid arthritis * , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[32]  W. Buchanan,et al.  Seronegative rheumatoid arthritis and HLA-DR4. , 1994, The Journal of rheumatology.

[33]  M. Prevoo,et al.  Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. , 1996, British journal of rheumatology.

[34]  R. Nienhuis,et al.  New Serum Factor in Patients with Rheumatoid Arthritis: The Antiperinuclear Factor * , 1964, Annals of the rheumatic diseases.

[35]  L. van de Putte,et al.  Immunogenetic heterogeneity of seronegative rheumatoid arthritis and the antiperinuclear factor. , 1990, Annals of the rheumatic diseases.

[36]  U. Wagner,et al.  HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[37]  H. Ménard,et al.  The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. , 1994, The Journal of rheumatology.

[38]  B. Leeb,et al.  Early arthritis therapy: rationale and current approach. , 1998, The Journal of rheumatology. Supplement.

[39]  M. Hakoda,et al.  Lack of association of HLA-DRB1 genotype with radiologic progression in Japanese patients with early rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[40]  J. Durieux,et al.  The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. , 1995, The Journal of clinical investigation.

[41]  H. Valkenburg,et al.  Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population. , 1984, Annals of the rheumatic diseases.

[42]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[43]  W. Graninger,et al.  Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis. , 1993, British journal of rheumatology.

[44]  T. Pincus,et al.  What is the natural history of rheumatoid arthritis? , 1993, Rheumatic diseases clinics of North America.

[45]  M. V. van Leeuwen,et al.  Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression. , 1998, British Journal of Rheumatology.

[46]  F. V. D. van den Hoogen,et al.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. , 1998, The Journal of clinical investigation.

[47]  A. Silman,et al.  The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association. , 1998, The Journal of rheumatology.

[48]  J. O'sullivan,et al.  The prevalence of rheumatoid arthritis. Follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts. , 1972, Annals of internal medicine.

[49]  A. van der Heide,et al.  Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[50]  E. Thorsby,et al.  HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. , 1980, Arthritis and rheumatism.

[51]  J. Fries,et al.  Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. , 1996, Arthritis and rheumatism.

[52]  T. Tuomi,et al.  Rheumatoid factors antedating clinical rheumatoid arthritis. , 1991, The Journal of rheumatology.

[53]  P. Emery,et al.  Early rheumatoid arthritis: time to aim for remission? , 1995, Annals of the rheumatic diseases.

[54]  T. Pincus,et al.  Associations of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis. , 1988, The American journal of medicine.

[55]  M. A. van 't Hof,et al.  Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. , 1990, Annals of the rheumatic diseases.

[56]  A. Silman,et al.  Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation. , 1996, The Journal of rheumatology.

[57]  C. Salvarani,et al.  Extraarticular manifestations of rheumatoid arthritis and HLA antigens in northern Italy. , 1992, The Journal of rheumatology.

[58]  M. V. van Leeuwen,et al.  Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. , 1994, The Journal of rheumatology.

[59]  H. Holman,et al.  Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.

[60]  M. Suarez‐Almazor,et al.  HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study. , 1995, The Journal of rheumatology.

[61]  B. Combe,et al.  Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. , 1999, The Journal of rheumatology.

[62]  C. Weyand,et al.  Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. , 1995, The Journal of clinical investigation.

[63]  M. Leirisalo-Repo,et al.  The prognostic value of HLA DR4 and B27 antigens in early rheumatoid arthritis. , 1993, Scandinavian journal of rheumatology.

[64]  A. Silman,et al.  Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the community. , 1993, Annals of the rheumatic diseases.

[65]  A. Silman,et al.  Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study. , 1999, Arthritis and rheumatism.

[66]  A. Silman,et al.  A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study , 1996, BMJ.

[67]  R Grahame,et al.  Seronegative and seropositive rheumatoid arthritis: similar diseases. , 1987, British journal of rheumatology.

[68]  K. Eberhardt,et al.  Functional impairment and disability in early rheumatoid arthritis--development over 5 years. , 1995, The Journal of rheumatology.

[69]  A. Silman,et al.  HLA and rheumatoid arthritis: a combined analysis of 440 British patients. , 1986, Annals of the rheumatic diseases.

[70]  F. Breedveld,et al.  Recruitment of patients with early rheumatoid arthritis -- the Netherlands experience. , 1996, The Journal of rheumatology. Supplement.

[71]  E. Thorsby,et al.  Seronegative and weakly seropositive rheumatoid arthritis differ from clearly seropositive rheumatoid arthritis in HLA class II associations. , 1994, The Journal of rheumatology.

[72]  E. Thorsby,et al.  The association between rheumatoid arthritis and the HLA antigen DR4. , 1983, Annals of the rheumatic diseases.

[73]  A. Masi.  Articular patterns in the early course of rheumatoid arthritis. , 1983, The American journal of medicine.

[74]  D. Heijde.  Joint erosions and patients with early rheumatoid arthritis , 1995 .

[75]  C. Clark,et al.  Anti-keratin antibodies in rheumatoid arthritis. , 1979, British medical journal.

[76]  P. Stastny.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. , 1978, The New England journal of medicine.

[77]  T. Koepsell,et al.  Rheumatoid factor, HLA-DR4, and allelic variants of DRB1 in women with recent-onset rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[78]  Larsen Hl.  Antikeratin antibodies in rheumatoid arthritis , 1991 .